Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Calithera Bio (CALA)
OTHER OTC:CALA
Calithera Bio (CALA) Stock Price & Analysis
453 Followers
CALA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.04 - $13.38
Previous Close$0.05
Volume8.67K
Average Volume (3M)322.10K
Market Cap
$243.26K
Enterprise Value-$9.46M
Total Cash (Recent Filing)$34.07M
Total Debt (Recent Filing)$2.02M
Price to Earnings (P/E)>-0.1
Beta0.79
Next Earnings
May 11, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-25.58
Shares Outstanding4,865,257
10 Day Avg. Volume21,182
30 Day Avg. Volume322,096
Standard Deviation0.28
R-Squared0.06
Alpha-0.07
Financial Highlights & Ratios
Price to Book (P/B)0.05
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)14.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.18
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Calithera Bio News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CALA FAQ
What was Calithera Bio’s price range in the past 12 months?
Calithera Bio lowest stock price was $0.04 and its highest was $13.38 in the past 12 months.
What is Calithera Bio’s market cap?
Currently, no data Available
When is Calithera Bio’s upcoming earnings report date?
Calithera Bio’s upcoming earnings report date is May 11, 2023 which is in 44 days.
How were Calithera Bio’s earnings last quarter?
Currently, no data Available
Is Calithera Bio overvalued?
According to Wall Street analysts Calithera Bio’s price is currently Overvalued.
Does Calithera Bio pay dividends?
Calithera Bio does not currently pay dividends.
What is Calithera Bio’s EPS estimate?
Calithera Bio’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Calithera Bio have?
Calithera Bio has 4,865,257 shares outstanding.
What happened to Calithera Bio’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Calithera Bio?
Among the largest hedge funds holding Calithera Bio’s share is PRIMECAP Management Co. It holds Calithera Bio’s shares valued at 1M.
---
Calithera Bio Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 13.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $46.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.6%
Last 30 Days ▼ 4.2%
Last 30 Days ▼ 4.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-99.52%
12-Months-Change
Fundamentals
Return on Equity
-216.47%
Trailing 12-Months
Asset Growth
-58.78%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Calithera Bio
Calithera Biosciences, Inc. engages in discovering and developing small molecule drugs that that target novel and critical metabolic pathway in tumor and cance-fighting immune cells. It offers programs such as Pipeline, Glutaminase Inhibitor, and Arginase Inhibitor. The company was founded by James A. Wells and Susan M. Molineaux on March 9, 2010 and is headquartered in South San Francisco, CA.
---
Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.
Bellerophon
―
Kintara Therapeutics
―
QSAM Biosciences
―
ProtoKinetix
―
Ridgefield Acquisition
―
---